FDA Approves Pramipexole For The Treatment Of Moderate-to-severe Primary Restless Legs Syndrome
13th Nov 2006, 08:27 GMT
Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved pramipexole, a non-ergot dopamine agonist, for the treatment of moderate to severe primary Restless Legs Syndrome (RLS). [click link for full article]
FDA Approves Pramipexole For The Treatment Of Moderate-to-severe Primary Restless Legs Syndrome related news:
- FDA Requirements Block Effective Treatment — Mises Economics Blog
- North American Gets Cancer Treatment OK — FDA News News from StratCenter.com
- ACAAI: Rodent Exposure Linked to High Asthma Rates in Children — MedPage Today.com Latest Headlines
- FDA Grants Priority Review for Soliris BLA for Treatment of Paroxysmal Nocturnal Hemoglobinuria — StratWire - Business of Healthcare NewsFeed
- New insight about the source of anxiety in Rett syndrome — EurekAlert! - Biology
- Dendreon Asks FDA to OK Prostate Drug — Government/ Industry Regulation News from StratCenter.com
- Ruboxistaurin Reduced Vision Loss in Patients With Moderate to Severe Non-Proliferative Diabetic Retinopathy in a New Study — Nephrology/ Dialysis News from StratCenter.com
- FDA Grants Priority Review for Soliris(TM) (eculizumab) BLA for Treatment of Paroxysmal Nocturnal Hemoglobinuria — PR Newswire: All Releases
- New Treatment for Ischemic Stroke on the Horizon — Medscape Headlines
- FDA Review on Novartis Galvus Extended — Government/ Industry Regulation News from StratCenter.com
Latest news from Health News from Medical News Today:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes